In this context, in a small group of severe COVID-19 patients, Ang II plasma concentration was found to be significantly higher than in healthy controls [49], strengthening the hypothesis of a direct link between tissue ACE2 downregulation with systemic RAS imbalance. The gene discussed is ACE2; the disease is COVID-19.